Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses

Sanfilippo disease (mucopolysaccharidosis type III, MPS III) is a severe metabolic disorder caused by accumulation of heparan sulfate (HS), one of glycosaminoglycans (GAGs), due to a genetic defect resulting in a deficiency of GAG hydrolysis. This disorder is characterized as the most severe neurolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kloska, Anna, Jakóbkiewicz-Banecka, Joanna, Narajczyk, Magdalena, Banecka-Majkutewicz, Zyta, Węgrzyn, Grzegorz
Formato: Texto
Lenguaje:English
Publicado: Springer US 2011
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070076/
https://www.ncbi.nlm.nih.gov/pubmed/21305347
http://dx.doi.org/10.1007/s11011-011-9233-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070076/
https://www.ncbi.nlm.nih.gov/pubmed/21305347
http://dx.doi.org/10.1007/s11011-011-9233-2

Ejemplares similares